Equitable Holdings, Inc. Abb Vie Inc. Transaction History

Equitable Holdings, Inc.

$9.9 Billion
Q3 2024

A detailed history of Equitable Holdings, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Equitable Holdings, Inc. holds 55,280 shares of ABBV stock, worth $9.95 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

55,280

Previous 60,825 9.12%

Holding current value

$9.95 Million

Previous $10.4 Million 4.64%

% of portfolio

0.11%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $908,492 - $1.11 Million	-5,545 Reduced 9.12%	55,280 $10.9 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $518,701 - $605,726	3,351 Added 5.83%	60,825 $10.4 Million
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $537,155 - $612,038	3,361 Added 6.21%	57,474 $10.5 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $835,094 - $940,512	6,069 Added 12.63%	54,113 $8.39 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $1.09 Million - $1.26 Million	8,163 Added 20.47%	48,044 $7.16 Million
Q2 2023 Aug 15, 2023	BUY	$132.51 - $164.9 $1.38 Million - $1.71 Million	10,385 Added 35.21%	39,881 $5.37 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $1.07 Million - $1.24 Million	7,429 Added 33.67%	29,496 $4.7 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $39,141 - $46,941	283 Added 1.3%	22,067 $3.57 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $80,526 - $92,358	600 Added 2.83%	21,784 $2.92 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $261,890 - $332,948	-1,903 Reduced 8.24%	21,184 $3.25 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $631,524 - $783,543	-4,785 Reduced 17.17%	23,087 $3.74 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $12,247 - $15,496	-114 Reduced 0.41%	27,872 $3.77 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $232,377 - $263,783	2,184 Added 8.46%	27,986 $3.02 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $97,950 - $109,122	-931 Reduced 3.48%	25,802 $2.91 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $101,481 - $111,719	992 Added 3.85%	26,733 $2.89 Million
Q4 2020 Feb 09, 2021	SELL	$80.49 - $108.67 $156,794 - $211,689	-1,948 Reduced 7.04%	25,741 $2.76 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $56,185 - $65,942	654 Added 2.42%	27,689 $2.43 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $765,689 - $1.02 Million	10,436 Added 62.87%	27,035 $2.65 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $839,209 - $1.27 Million	-13,011 Reduced 43.94%	16,599 $1.27 Million
Q4 2019 Feb 18, 2020	BUY	$72.13 - $90.25 $2.14 Million - $2.67 Million	29,610 New	29,610 $2.62 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Equitable Holdings, Inc. with notifications on news.

Account

Equitable Holdings, Inc. Abb Vie Inc. Transaction History